Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Spectral Medical Inc.TSX: EDT.TO

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables declines year over year

Q1 FY2026 accounts payables of CA$266K fell 67.6% year over year, ahead of the -167.0% change in trailing-twelve-month accounts payables.

Context

  • Accounts payables amounted to 10.9% of revenue in FY2025, up 8.6 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -67.6% holds above the trailing-twelve-month pace of -167.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$266K+152.7% QoQ
Last fiscal yearDec 2025
-CA$265K+419.6% YoY
LTMMar 2026
-CA$819K-167.0% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-67.6%——
1 year+419.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

CAD · from the cash flow

Latest · FY2025
(265K) CAD
Year-over-year change
-419.6%

Accounts Payables vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -167.0% is the 7th highest of 8, against a peer median of -71.9%.
  • Accounts payables amounts to 29.7% of revenue for EDT.TO, versus a peer median of 2.0%.
EDT.TO Competitors
Accounts Payables for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$8.04M CAD-159.1%-0.1%2.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$4.35M CAD-71.9%—1.4%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$3.31M USD+279.8%+22.0%—
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.24M USD+255.2%—2.4%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$973.33K USD+1180.7%-4.7%1.9%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$933.52K CAD-215.0%—1.4%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$819K CAD-167.0%—29.7%
PRN.TOProfound Medical Corp.LTM Mar 2026$379.28K USD-77.5%—2.0%
Peer median (excluding EDT.TO) —-71.9%-0.1%2.0%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.79M)(11.25M)(15.66M)(15.4M)(47.69M)
Depreciation & Amortization294K272K218K251K250K
Deferred Income Tax00000
Stock-Based Compensation1.26M1.2M1.49M1.68M2.12M
Change in Working Capital(1.76M)579K(406K)1.01M(189K)
Accounts Receivables55K(877K)870K(265K)246K
Inventory(51K)(47K)(26K)137K(148K)
Accounts Payables(1.11M)1.65M(267K)(51K)(265K)
Other Working Capital(656K)(142K)(983K)1.19M(22K)
Other Non-Cash Items288K(698K)3.64M3.64M33.88M
Operating Cash Flow(8.7M)(9.9M)(10.72M)(8.82M)(9.52M)
Capital Expenditures(483K)(33K)(185K)(27K)(195K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities158K0000
Investing Cash Flow(325K)(33K)(185K)(27K)(195K)
Debt Repayment(113K)3.71M3.93M9.74M9.67M
Common Stock Issued10M4.03M01.15M3.4M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.28M1.72M1.51M(2.02M)(155K)
Financing Cash Flow12.17M9.46M5.44M8.88M12.91M
Effect of Forex Changes(56K)0000
Net Change in Cash3.08M(476K)(5.46M)36K1.08M
Free Cash Flow(9.18M)(9.93M)(10.91M)(8.85M)(9.72M)

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.